We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Correction: Reducing the harms of xylazine: clinical approaches, research deficits, and public health context.
- Authors
Zagorski, Claire M.; Hosey, Rebecca A.; Moraff, Christopher; Ferguson, Aaron; Figgatt, Mary; Aronowitz, Shoshana; Stahl, Natalie E.; Hill, Lucas G.; McElligott, Zoe; Dasgupta, Nabarun
- Abstract
This correction notice is for an article titled "Reducing the harms of xylazine: clinical approaches, research deficits, and public health context" published in the Harm Reduction Journal. The correction addresses an error in the original article regarding the legal status of xylazine. The corrected paragraph clarifies that xylazine is unscheduled at the federal level and is only illegal in Florida. The authors caution against scheduling xylazine as it would hinder research on its health impacts, toxicology, and safety profile, and disrupt pre-clinical research involving animals. The correction notice is provided by multiple authors and the publisher, Springer Nature, maintains neutrality regarding jurisdictional claims and institutional affiliations.
- Subjects
FLORIDA; XYLAZINE; PUBLIC health; AUTHOR-publisher relations; HARM reduction; STATUS (Law)
- Publication
Harm Reduction Journal, 2023, Vol 20, Issue 1, p1
- ISSN
1477-7517
- Publication type
Article
- DOI
10.1186/s12954-023-00903-w